A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Aprobarbital
Dalteparin
The risk or severity of bleeding can be increased when Edoxaban is combined with Dalteparin.
Aprobarbital
Danaparoid
The risk or severity of bleeding can be increased when Edoxaban is combined with Danaparoid.
Aprobarbital
Amediplase
The risk or severity of bleeding can be increased when Edoxaban is combined with Amediplase.
Aprobarbital
Otamixaban
The risk or severity of bleeding can be increased when Edoxaban is combined with Otamixaban.
Aprobarbital
Astaxanthin
The risk or severity of bleeding can be increased when Edoxaban is combined with Astaxanthin.
Aprobarbital
Cangrelor
The risk or severity of bleeding can be increased when Edoxaban is combined with Cangrelor.
Aprobarbital
Idraparinux
The risk or severity of bleeding can be increased when Edoxaban is combined with Idraparinux.
Aprobarbital
Semuloparin
The risk or severity of bleeding can be increased when Edoxaban is combined with Semuloparin.
Aprobarbital
Sulodexide
The risk or severity of bleeding can be increased when Edoxaban is combined with Sulodexide.
Aprobarbital
Prasugrel
The risk or severity of bleeding can be increased when Edoxaban is combined with Prasugrel.
Aprobarbital
Fibrinolysin
The risk or severity of bleeding can be increased when Edoxaban is combined with Fibrinolysin.
Aprobarbital
Beraprost
The risk or severity of bleeding can be increased when Edoxaban is combined with Beraprost.
Aprobarbital
Ancrod
The risk or severity of bleeding can be increased when Edoxaban is combined with Ancrod.
Aprobarbital
Defibrotide
The risk or severity of bleeding can be increased when Edoxaban is combined with Defibrotide.
Aprobarbital
Desmoteplase
The risk or severity of bleeding can be increased when Edoxaban is combined with Desmoteplase.
Aprobarbital
Ximelagatran
The risk or severity of bleeding can be increased when Edoxaban is combined with Ximelagatran.
Aprobarbital
Coumarin
The risk or severity of bleeding can be increased when Edoxaban is combined with Coumarin.
Aprobarbital
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Edoxaban is combined with 4-hydroxycoumarin.
Aprobarbital
Hyodeoxycholic Acid
The risk or severity of bleeding and bruising can be increased when Edoxaban is combined with Hyodeoxycholic Acid.
Aprobarbital
Dehydrocholic acid
The risk or severity of bleeding and bruising can be increased when Edoxaban is combined with Dehydrocholic acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3